StockData
MariMed Inc. logo

MariMed Inc. (MRMD) stock

MRMDOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.06−0.00 (-3.39%)

Close on Oct 19, 2026Market cap $22.97MP/E –Yield –

MariMed net income

Net income is the profit left for shareholders after every expense, interest and tax.

MariMed's net income for the twelve months ending Sep 30, 2026 was -$15.51M. For fiscal 2025 it was -$14.48M. The highest annual figure on record is $13.47M in fiscal 2022.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$14.48M–
FY2024Dec 31, 2024-$12.47M–
FY2023Dec 31, 2023-$16.03M-219.0%
FY2022Dec 31, 2022$13.47M+86.4%
FY2021Dec 31, 2021$7.23M+237.0%
FY2020Dec 31, 2020$2.14M–
FY2019Dec 31, 2019-$81.18M–
FY2018Dec 31, 2018-$13.60M–
FY2017Dec 31, 2017-$1.19M–
FY2016Dec 31, 2016-$198.85K–
FY2015Dec 31, 2015-$1.85M–
FY2014Dec 31, 2014-$7.42M–
FY2013Dec 31, 2013-$535.61K–
FY2012Dec 31, 2012-$809.54K–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$3.51M–
Q2 FY2026Jun 30, 2026-$3.59M–
Q1 FY2026Mar 31, 2026-$3.79M–
Q4 FY2025Dec 31, 2025-$4.63M–
Q3 FY2025Sep 30, 2025-$2.95M–
Q2 FY2025Jun 30, 2025-$1.39M–
Q1 FY2025Mar 31, 2025-$5.51M–
Q4 FY2024Dec 31, 2024-$8.27M–
Q3 FY2024Sep 30, 2024-$1.01M–
Q2 FY2024Jun 30, 2024-$1.65M–
Q1 FY2024Mar 31, 2024-$1.30M–
Q4 FY2023Dec 31, 2023-$10.17M-314.0%
Q3 FY2023Sep 30, 2023-$4.26M-257.4%
Q2 FY2023Jun 30, 2023-$958.00K-152.6%
Q1 FY2023Mar 31, 2023-$645.00K-115.4%
Q4 FY2022Dec 31, 2022$4.75M–
Q3 FY2022Sep 30, 2022$2.71M-35.9%
Q2 FY2022Jun 30, 2022$1.82M-55.8%
Q1 FY2022Mar 31, 2022$4.19M+152.5%
Q4 FY2021Dec 31, 2021-$6.51M–
Q1 FY2021Mar 31, 2021$4.22M–
Q4 FY2020Dec 31, 2020$4.12M–
Q3 FY2020Sep 30, 2020$1.66M–
Q2 FY2020Jun 30, 2020-$1.21M-126.0%
Q1 FY2020Mar 31, 2020-$2.42M–
Q4 FY2019Dec 31, 2019-$78.44M–
Q3 FY2019Sep 30, 2019-$7.40M–
Q2 FY2019Jun 30, 2019$4.68M–
Q1 FY2019Mar 31, 2019-$23.21K–
Q4 FY2018Dec 31, 2018-$7.74M–
Q3 FY2018Sep 30, 2018-$3.50M–
Q2 FY2018Jun 30, 2018-$461.97K-184.5%
Q1 FY2018Mar 31, 2018-$1.90M–
Q4 FY2017Dec 31, 2017-$1.32M-11711.5%
Q3 FY2017Sep 30, 2017-$392.45K–
Q2 FY2017Jun 30, 2017$547.00K–
Q1 FY2017Mar 31, 2017-$33.24K–
Q4 FY2016Dec 31, 2016$11.34K–
Q3 FY2016Sep 30, 2016-$60.82K–

More MariMed figures

See a number that looks wrong?